Transaction #34152 · Form 4 · 0001193125-26-427830
Inhibikase Therapeutics, Inc. · Stock award · Stock Option (Right to Buy)
Inhibikase Therapeutics, Inc. · Transacted October 19, 2026 · Filed October 21, 2026
What does this filing report?
An SEC Form 4 filing for Inhibikase Therapeutics, Inc. records a stock award involving Stock Option (Right to Buy) on October 19, 2026. The reported quantity was 310,000. The filing date is October 21, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001750149
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 310,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 310,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2026, 4:10 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Wasserman Scott M. ↗
Director
CIK 0002118767
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 310,000
- Conversion / exercise price
- 1.645
- Exercise date
- Not reported
- Expiration date
- October 19, 2036
Filing footnotes & remarks
- F1
- The options will vest and become exercisable in equal annual installments over three years commencing from October 19, 2026, subject to the Reporting Person's continued service through each such vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.